These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 10543757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
    Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [Abstract] [Full Text] [Related]

  • 8. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW, Patron RL, Goldstein BP, Archer GL.
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [Abstract] [Full Text] [Related]

  • 9. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF.
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
    [Abstract] [Full Text] [Related]

  • 10. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Dailey CF, Dileto-Fang CL, Buchanan LV, Oramas-Shirey MP, Batts DH, Ford CW, Gibson JK.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):257-60. PubMed ID: 2327773
    [Abstract] [Full Text] [Related]

  • 13. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Lamp KC, Bailey EM, Rybak MJ.
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1192-7. PubMed ID: 1329613
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
    Kim YS, Liu Q, Chow LL, Chambers HF, Täuber MG.
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
    [Abstract] [Full Text] [Related]

  • 15. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH, Levine DP, Price S, Rybak MJ.
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):382-4. PubMed ID: 3640590
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS, Lam K.
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [Abstract] [Full Text] [Related]

  • 20. Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.
    Anguita-Alonso P, Rouse MS, Piper KE, Steckelberg JM, Patel R.
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1263-7. PubMed ID: 16569838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.